Matches in Wikidata for { <http://www.wikidata.org/entity/Q98299777> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q98299777 description "article scientifique publié en 2020" @default.
- Q98299777 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q98299777 description "scientific article published on 23 May 2020" @default.
- Q98299777 description "wetenschappelijk artikel" @default.
- Q98299777 description "наукова стаття, опублікована 23 травня 2020" @default.
- Q98299777 description "գիտական հոդված հրատարակված 2020 թվականի մայիսի 23-ին" @default.
- Q98299777 name "Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled ran" @default.
- Q98299777 name "Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled ran" @default.
- Q98299777 type Item @default.
- Q98299777 label "Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled ran" @default.
- Q98299777 label "Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled ran" @default.
- Q98299777 prefLabel "Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled ran" @default.
- Q98299777 prefLabel "Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled ran" @default.
- Q98299777 P1433 Q98299777-FF3C3D49-E217-46C2-BA73-B6BB781A00AC @default.
- Q98299777 P1476 Q98299777-D185713B-D27A-4B63-8CBD-E96904D4EC80 @default.
- Q98299777 P2093 Q98299777-069F618B-1B38-4F0E-95A2-CF4716D86509 @default.
- Q98299777 P2093 Q98299777-293BED26-F839-4AD7-BB1D-7FAC2C65C1B2 @default.
- Q98299777 P2093 Q98299777-33B0F71B-7942-44A8-9016-DB2B7F0EDCD1 @default.
- Q98299777 P2093 Q98299777-4518091E-8B2F-402E-8284-C1CB0C44AE6D @default.
- Q98299777 P2093 Q98299777-61D10BCF-9B0E-4BCD-868D-CF1DF141E322 @default.
- Q98299777 P2093 Q98299777-6D061574-9D0E-45A8-B7CA-6CD96C3DF5D1 @default.
- Q98299777 P2093 Q98299777-6D110991-DD90-4B62-A1AB-3DEE9A3DBACB @default.
- Q98299777 P2093 Q98299777-6EE9A7DB-B850-40A5-8E0A-8076A05AE7C5 @default.
- Q98299777 P2093 Q98299777-9515CB83-3420-410F-B7FB-ED7F6E692CC4 @default.
- Q98299777 P2093 Q98299777-AA4732B7-7890-4B46-8B8A-6A9BAFEBD829 @default.
- Q98299777 P2093 Q98299777-EBD0E3E1-AB47-49F7-86FD-AFD020228E82 @default.
- Q98299777 P304 Q98299777-667F7B89-0DFA-45F2-8CA2-32558BA05AC3 @default.
- Q98299777 P31 Q98299777-9A8C3FBD-6141-4075-9D5B-7418759059AC @default.
- Q98299777 P356 Q98299777-C73C4017-29B5-41F7-B848-144763FC4317 @default.
- Q98299777 P478 Q98299777-A5CE2EA5-2E41-438D-8053-945053B37A89 @default.
- Q98299777 P577 Q98299777-687B4B9A-38F7-4EB9-9CBC-385213B5AC05 @default.
- Q98299777 P698 Q98299777-986233C5-10D3-46F3-A2FD-70C70C6080DB @default.
- Q98299777 P921 Q98299777-5335E0DD-67C0-466B-8B81-AC8930836DA4 @default.
- Q98299777 P921 Q98299777-6F94B0C5-6F97-4048-9864-5AFAF5232D73 @default.
- Q98299777 P356 J.RESMER.2020.100770 @default.
- Q98299777 P698 32777737 @default.
- Q98299777 P1433 Q96321055 @default.
- Q98299777 P1476 "Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial" @default.
- Q98299777 P2093 "A Caille" @default.
- Q98299777 P2093 "B Crestani" @default.
- Q98299777 P2093 "H Nunes" @default.
- Q98299777 P2093 "J Cadranel" @default.
- Q98299777 P2093 "J-Marc Naccache" @default.
- Q98299777 P2093 "M Ferreira" @default.
- Q98299777 P2093 "OrphaLung" @default.
- Q98299777 P2093 "R Borie" @default.
- Q98299777 P2093 "S Marchand-Adam" @default.
- Q98299777 P2093 "T Bejan-Angoulvant" @default.
- Q98299777 P2093 "V Cottin" @default.
- Q98299777 P304 "100770" @default.
- Q98299777 P31 Q13442814 @default.
- Q98299777 P356 "10.1016/J.RESMER.2020.100770" @default.
- Q98299777 P478 "78" @default.
- Q98299777 P577 "2020-05-23T00:00:00Z" @default.
- Q98299777 P698 "32777737" @default.
- Q98299777 P921 Q3907637 @default.
- Q98299777 P921 Q412323 @default.